Eledon Pharmaceuticals (ELDN) Enterprise Value (2016 - 2017)
Historic Enterprise Value for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$19.2 million.
- Eledon Pharmaceuticals' Enterprise Value fell 286.63% to -$19.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$19.2 million, marking a year-over-year decrease of 286.63%. This contributed to the annual value of -$1.1 million for FY2016, which is 9529.2% up from last year.
- According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Enterprise Value is -$19.2 million, which was down 286.63% from -$22.6 million recorded in Q2 2017.
- In the past 5 years, Eledon Pharmaceuticals' Enterprise Value registered a high of -$1.1 million during Q4 2016, and its lowest value of -$105.5 million during Q3 2014.
- Moreover, its 5-year median value for Enterprise Value was -$24.2 million (2015), whereas its average is -$38.3 million.
- As far as peak fluctuations go, Eledon Pharmaceuticals' Enterprise Value tumbled by 24856.74% in 2015, and later soared by 9529.2% in 2016.
- Over the past 5 years, Eledon Pharmaceuticals' Enterprise Value (Quarter) stood at -$31.8 million in 2013, then tumbled by 231.48% to -$105.3 million in 2014, then skyrocketed by 77.18% to -$24.0 million in 2015, then soared by 95.29% to -$1.1 million in 2016, then crashed by 1594.43% to -$19.2 million in 2017.
- Its Enterprise Value was -$19.2 million in Q3 2017, compared to -$22.6 million in Q2 2017 and -$24.4 million in Q1 2017.